These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7432099)

  • 1. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra.
    Fadda F; Argiolas A; Melis MR; Serra G; Gessa GL
    Life Sci; 1980 Sep; 27(11):979-86. PubMed ID: 7432099
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acute and chronic ethanol on dopamine synthesis in the caudate nucleus, substantia nigra and frontal cortex.
    Fadda F; Argiolas A; Melis MR; Serra G
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2553-8. PubMed ID: 7470302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol on the metabolism of regional brain dopamine.
    Fadda F; Argiolas A; Melis MR; Serra G; Congia S
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2559-63. PubMed ID: 7470303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Serra G; Gessa GL
    Brain Res; 1979 Oct; 175(1):178-82. PubMed ID: 487148
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.
    Pericić D; Walters JR
    J Pharm Pharmacol; 1976 Jun; 28(6):527-30. PubMed ID: 7658
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F; Argiolas A; Stefanini E; Gessa GL
    Life Sci; 1977 Aug; 21(3):411-7. PubMed ID: 895373
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--II. Studies using ibotenic acid injection of the parafascicular-intralaminar nuclei.
    Kilpatrick IC; Jones MW; Johnson BJ; Cornwall J; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):979-90. PubMed ID: 3796824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    Brain Res; 1974 Mar; 68(2):253-60. PubMed ID: 4826898
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of dopamine in the ventral tegmental area of rat.
    Fadda F; Melis MR; Argiolas A; Perra G
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V
    Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K; Shibata R
    Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G; Saiani L; Spano PF; Trabucchi M
    Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization.
    Kilpatrick IC; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine, a modulator of carbohydrate metabolism in the caudate nucleus.
    Anchors JM; Garcia-Rill E
    Brain Res; 1977 Sep; 133(1):183-9. PubMed ID: 902086
    [No Abstract]   [Full Text] [Related]  

  • 20. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
    Constantinidis J; Bartholini G; Tissot R; Pletscher A
    Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.